Get started
HAISCO PHARMACEUTIHAISCO PHARMACEUTIHAISCO PHARMACEUTI

HAISCO PHARMACEUTI

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

002653 chart


Full chart

002653 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪50.65 B‬ CNY
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
128.27
Basic EPS (TTM)
0.35 CNY
Net income (FY)
‪395.46 M‬ CNY
Revenue (FY)
‪3.67 B‬ CNY
Shares float
‪493.87 M‬
Beta (1Y)
0.27

Employees


Employees (FY)
‪5.34 K‬
Change (1Y)
−111 −2.04%
Revenue / Employee (1Y)
‪688.16 K‬ CNY
Net income / Employee (1Y)
‪74.10 K‬ CNY

About HAISCO PHARMACEUTI


Sector
Health Technology
Industry
Pharmaceuticals: Generic
CEO
Xiu Lian Fan
Website
haisco.com
Headquarters
Shannan
Founded
2000
ISIN
CNE100001BC7
FIGI
BBG002B5GWV9
Haisco Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products and medical equipment. It offers narcotic analgesics, endocrine system, enteral parenteral nutrition, neuropsychiatric, cardiovascular, tumor related, and digestive liver disease drugs. The company was founded in 2000 and is headquartered in Shannan, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

002653 news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 002653.

Frequently Asked Questions


The current price of 002653 is 45.20 CNY — it has decreased by −0.48% in the past 24 hours. Watch HAISCO PHARMACEUTI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange HAISCO PHARMACEUTI stocks are traded under the ticker 002653.
002653 stock has risen by 7.80% compared to the previous week, the month change is a 32.75% rise, over the last year HAISCO PHARMACEUTI has showed a 68.91% increase.
We've gathered analysts' opinions on HAISCO PHARMACEUTI future price: according to them, 002653 price has a max estimate of 59.54 CNY and a min estimate of 46.99 CNY. Watch 002653 chart and read a more detailed HAISCO PHARMACEUTI stock forecast: see what analysts think of HAISCO PHARMACEUTI and suggest that you do with its stocks.
002653 reached its all-time high on Apr 11, 2025 with the price of 47.45 CNY, and its all-time low was 6.15 CNY and was reached on Jan 19, 2012. View more price dynamics on 002653 chart.
See other stocks reaching their highest and lowest prices.
002653 stock is 6.26% volatile and has beta coefficient of 0.27. Track HAISCO PHARMACEUTI stock price on the chart and check out the list of the most volatile stocks — is HAISCO PHARMACEUTI there?
Today HAISCO PHARMACEUTI has the market capitalization of ‪50.87 B‬, it has increased by 1.55% over the last week.
Yes, you can track HAISCO PHARMACEUTI financials in yearly and quarterly reports right on TradingView.
HAISCO PHARMACEUTI is going to release the next earnings report on Apr 23, 2025. Keep track of upcoming events with our Earnings Calendar.
002653 net income for the last quarter is ‪13.64 M‬ CNY, while the quarter before that showed ‪217.10 M‬ CNY of net income which accounts for −93.72% change. Track more HAISCO PHARMACEUTI financial stats to get the full picture.
As of Apr 15, 2025, the company has ‪5.34 K‬ employees. See our rating of the largest employees — is HAISCO PHARMACEUTI on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HAISCO PHARMACEUTI EBITDA is ‪391.74 M‬ CNY, and current EBITDA margin is 11.07%. See more stats in HAISCO PHARMACEUTI financial statements.
Like other stocks, 002653 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HAISCO PHARMACEUTI stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HAISCO PHARMACEUTI technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HAISCO PHARMACEUTI stock shows the strong buy signal. See more of HAISCO PHARMACEUTI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.